These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28259945)

  • 1. Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Wang CY; Xu ZB; Wang JP; Jiao Y; Zhang B
    Int J Oncol; 2017 Apr; 50(4):1221-1232. PubMed ID: 28259945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Wang JP; Jiao Y; Wang CY; Xu ZB; Zhang B
    Int J Oncol; 2017 Jan; 50(1):149-160. PubMed ID: 27922689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma protein inhibits IFN-gamma induced apoptosis.
    Berry DE; Lu Y; Schmidt B; Fallon PG; O'Connell C; Hu SX; Xu HJ; Blanck G
    Oncogene; 1996 Apr; 12(8):1809-19. PubMed ID: 8622902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
    Shinohara H; Zhou J; Yoshikawa K; Yazumi S; Ko K; Yamaoka Y; Mizukami T; Yoshida T; Akinaga S; Tamaoki T; Motoda H; Benedict WF; Takahashi R
    Br J Cancer; 2000 Oct; 83(8):1039-46. PubMed ID: 10993652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumour-specific targeting of p53-induced apoptosis.
    Steinhoff C; Prior A; Reichmann G; Seifert HH; Schulz WA
    Int J Oncol; 2002 Nov; 21(5):1033-40. PubMed ID: 12370752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context.
    Dean JL; McClendon AK; Stengel KR; Knudsen ES
    Oncogene; 2010 Jan; 29(1):68-80. PubMed ID: 19802012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and RB expression predict progression in T1 bladder cancer.
    Grossman HB; Liebert M; Antelo M; Dinney CP; Hu SX; Palmer JL; Benedict WF
    Clin Cancer Res; 1998 Apr; 4(4):829-34. PubMed ID: 9563875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. αB-crystallin promotes oncogenic transformation and inhibits caspase activation in cells primed for apoptosis by Rb inactivation.
    Petrovic V; Malin D; Cryns VL
    Breast Cancer Res Treat; 2013 Apr; 138(2):415-25. PubMed ID: 23471649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
    Busch M; Große-Kreul J; Wirtz JJ; Beier M; Stephan H; Royer-Pokora B; Metz K; Dünker N
    Int J Cancer; 2017 Aug; 141(3):549-560. PubMed ID: 28481041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis.
    Parisi T; Bronson RT; Lees JA
    Oncogene; 2009 Jan; 28(4):500-8. PubMed ID: 18997819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.
    Logothetis CJ; Xu HJ; Ro JY; Hu SX; Sahin A; Ordonez N; Benedict WF
    J Natl Cancer Inst; 1992 Aug; 84(16):1256-61. PubMed ID: 1640485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation.
    Goodrich DW; Chen Y; Scully P; Lee WH
    Cancer Res; 1992 Apr; 52(7):1968-73. PubMed ID: 1551125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
    Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y; Fan Y
    Tumour Biol; 2016 Jun; 37(6):7371-81. PubMed ID: 26676636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.
    Takahashi R; Hashimoto T; Xu HJ; Hu SX; Matsui T; Miki T; Bigo-Marshall H; Aaronson SA; Benedict WF
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5257-61. PubMed ID: 2052605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.